☆ 4.7 Review

COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

Jordi Colmenero et al.

Summary: This study revealed that liver transplant patients have a higher risk of contracting COVID-19, but their mortality rate is lower than the general population. Baseline immunosuppression containing mycophenolate was identified as an independent predictor of severe COVID-19, especially at higher doses.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study

Nabeel Khan et al.

Summary: A nationwide retrospective cohort study in the US Veterans' Affairs healthcare system found that patients with inflammatory bowel disease (IBD) did not have a significantly increased risk of developing SARS-CoV-2 infection compared to patients without IBD.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Surgery

Liver transplantation in a patient after COVID-19-Rapid loss of antibodies and prolonged viral RNA shedding

Hanno Niess et al.

Summary: Currently, there is limited understanding of the duration and effectiveness of immunity following SARS-CoV-2 infection, as well as potential adverse late effects. This uncertainty raises questions about the safety of offering liver transplantation to patients who have recovered from COVID-19. In this case report, successful liver transplantation was performed shortly after recovery, but partial seroreversion and prolonged shedding of viral RNA were observed.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection

Article Surgery

COVID-19 in transplant recipients: The Spanish experience

Elisabeth Coll et al.

Summary: This study reported the experience of solid organ and hematopoietic stem cell transplant recipients diagnosed with COVID-19 in Spain until July 13, 2020. The incidence of COVID-19 in transplant recipients was higher than the general population. Most patients required hospitalization, and adjusting immunosuppression could improve survival rates. Risk factors for death included age, lung transplantation, and hospital-acquired COVID-19.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases

Erica J. Brenner et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling

Jay Vasant Patankar et al.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease

Mayte Suarez-Farinas et al.

Summary: The study shows that the COVID-19 virus has the ability to invade the intestines, and medications used by IBD patients do not significantly affect receptor expression in uninflamed intestines. There are shared molecular networks between COVID-19 infection and IBD.

GASTROENTEROLOGY (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Modulating immunosuppression in liver transplant patients with COVID-19

Manuel Rodriguez-Peralvarez et al.

GUT (2021)

Add to Collection

Article Gastroenterology & Hepatology

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Ryan C. Ungaro et al.

Summary: Combination therapy and thiopurines may be associated with an increased risk of severe COVID-19, while no significant differences were observed when comparing classes of biologicals. These findings warrant confirmation in large population-based cohorts.

GUT (2021)

Add to Collection

Article Gastroenterology & Hepatology

Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid Spain

Ivan Guerra et al.

Summary: Infection with SARS-CoV-2 in patients with inflammatory bowel disease (IBD) is not rare, with most patients having a mild disease course. Immunotherapy is not associated with greater severity of COVID-19, and myalgias may be related to a milder clinical course.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases

Kristin E. Burke et al.

Summary: In a multi-institutional cohort of patients with IBD, the use of systemic immunosuppression was not associated with an increased risk of COVID-19, while obesity was identified as a risk factor for COVID-19.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection

Article Cell Biology

Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls

Armin Sadeghi et al.

Summary: In COVID-19 patients, an increase in Th17 cells and decrease in Treg cells are associated with hyperinflammation and disease progression, with a higher inflammatory ratio observed in deceased patients compared to those who improved, indicating the critical role of inflammation in patient mortality.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon

Bram Verstockt et al.

Summary: In patients with inflammatory bowel disease, intestinal inflammation alters the coreceptors for SARS-CoV-2 in the intestine, leading to dysregulation of ACE2 in the ileum and colon. Inflammatory stimuli upregulate ACE2 expression in organoids from UC patients, while anti-TNF therapy restores proper ACE2 regulation in responders.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium

Xavier Verhelst et al.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Immunology

Successful liver transplantation in a patient recovered from COVID-19

Abhay Dhand et al.

Summary: Organ transplantation in potential candidates who have recently recovered from COVID-19 presents challenges and uncertainties, but successful cases demonstrate that transplantation can be performed with careful evaluation, donor selection, and personalized risk-benefit analysis even after recovery from COVID-19.

TRANSPLANT INFECTIOUS DISEASE (2021)

Add to Collection

Article Immunology

COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management

Marta Miarons et al.

Summary: This study investigated the epidemiological and clinical characteristics of solid organ transplant patients during the SARS-CoV-2 epidemic in Barcelona, Spain. The results showed a trend towards higher mortality in SOT recipients compared to controls, with a notable risk of drug-drug interactions.

TRANSPLANTATION (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Carlo Salvarani et al.

Summary: This study evaluated the use of tocilizumab in hospitalized COVID-19 pneumonia patients and found no significant benefit compared to standard care. Further randomized clinical trials with blinded, placebo-controlled methods are needed to confirm these results and explore potential applications of tocilizumab in different stages of the disease.

JAMA INTERNAL MEDICINE (2021)

Add to Collection

Review Pediatrics

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

Rachel Harwood et al.

Summary: PIMS-TS is a newly discovered condition associated with COVID-19, and a national consensus management pathway has been developed for UK clinicians caring for affected children. The guidance emphasizes the importance of a multidisciplinary team in decision-making and recommends treatment options including supportive care, immunoglobulin, steroids, and biological therapies. This guidance provides a solid framework for clinicians caring for children with PIMS-TS in the UK and will be updated based on future evidence.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Add to Collection

Article Gastroenterology & Hepatology

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs

Fabrizio Bossa et al.

Summary: The study found that treatment with biologic drugs does not increase the risk of SARS-CoV-2 infection in patients with inflammatory bowel disease. The majority of patients did not get infected with the virus, and only a small number experienced mild symptoms, with very few requiring hospitalization.

DIGESTIVE AND LIVER DISEASE (2021)

Add to Collection

Article Gastroenterology & Hepatology

Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

Luca S. Belli et al.

Summary: Despite concerns, data from adult liver transplant recipients with COVID-19 infection in Europe shows that age over 70, diabetes, and chronic kidney disease are associated with increased risk of death, while the use of tacrolimus may improve survival rates in these patients.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Corey A. Siegel et al.

GUT (2021)

Add to Collection

Article Gastroenterology & Hepatology

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry

Manasi Agrawal et al.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection

Review Gastroenterology & Hepatology

COVID-19 in Chronic Liver Disease and Liver Transplantation A Clinical Review

Abdul Mohammed et al.

Summary: The COVID-19 pandemic has posed challenges to clinicians caring for patients with chronic liver disease, with evidence suggesting that chronic liver diseases may have adverse effects on the clinical outcomes of COVID-19 patients. In this scenario, synthesizing recommendations from various hepatology societies becomes crucial.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)

Add to Collection

Article Immunology

The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19

Enric Monreal et al.

Summary: Research revealed that COVID-19 hospitalized patients receiving immunosuppressive treatment for autoimmune diseases had a lower risk of developing severe ARDS, while those receiving immunosuppressive treatment without autoimmune diseases may have a higher mortality rate.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy

Roberto Berte et al.

Summary: The seroprevalence of SARS-CoV-2 in IBD patients treated with biologic therapy reflects values measured in the local general population. Specific symptoms and contact history with SARS-CoV-2-infected individuals strongly increase the likelihood of SARS-CoV-2 seropositivity.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Article Gastroenterology & Hepatology

SARS-CoV-2 infection in patients with autoimmune hepatitis

Thomas Marjot et al.

Summary: Patients with autoimmune hepatitis (AIH) did not have an increased risk of adverse outcomes compared to other causes of chronic liver disease (CLD) and to matched cases without liver disease, despite the use of immunosuppressive treatment.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Cell Biology

Neutrophils mediate Th17 promotion in COVID-19 patients

Zuzana Parackova et al.

Summary: Neutrophils play a crucial role in the pathophysiology of COVID-19 by affecting the polarization of T cells, leading to a skewed Th1/Th17 adaptive immune response. Targeting neutrophils and Th17 may represent a potential therapeutic strategy for severe COVID-19 patients.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Genetic mechanisms of critical illness in COVID-19

Erola Pairo-Castineira et al.

Summary: In critically ill patients with COVID-19, host genetic variants associated with antiviral defense mechanisms and inflammatory organ damage were identified through a genome-wide association study. These genetic signals provide potential targets for therapeutic development and repurposing of existing drugs. Large-scale randomized clinical trials will be essential to confirm the effectiveness of targeted treatment strategies.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Gastroenterology & Hepatology

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

James L. Alexander et al.

Summary: SARS-CoV-2 vaccination in patients with IBD is supported due to anticipated low risks, despite some concerns that protective immune responses may be diminished in certain patients. Further research is needed to address vaccine hesitancy, the impact of immunosuppression, and the search for predictive biomarkers of vaccine success.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19

Harsh Shah et al.

Summary: The outbreak of COVID-19 caused by SARS-CoV-2 has become a pandemic, leading to a higher risk of severe infection in individuals with hypertension, obesity, diabetes, and related complications. There is an urgent need to develop evidence-based treatment methods to effectively manage chronic diseases in COVID-19 patients without affecting the severity of the infection.

ACTA DIABETOLOGICA (2021)

Add to Collection

Article Gastroenterology & Hepatology

Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease

Alka A. Potdar et al.

Summary: The study identified differences in intestinal ACE2 expression levels in patients with Crohn's disease and ulcerative colitis, associated with inflammation and disease severity. Treatment with anti-cytokine therapy restored ACE2 expression, potentially impacting outcomes of severe acute respiratory syndrome coronavirus 2 infection.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID‐19 Infection in Patients with Liver Disease

Oren K. Fix et al.

HEPATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Add to Collection

News Item Medicine, General & Internal

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

Nicholas A. Kennedy et al.

Summary: The study found that patients with inflammatory bowel disease treated with infliximab had attenuated serological responses to SARS-CoV-2 infection. Additionally, the serological response to SARS-CoV-2 infection in the infliximab-treated group was further blunted by concomitant use of immunomodulators.

GUT (2021)

Add to Collection

Review Oncology

Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review

C. Nahshon et al.

Summary: The prevalence of cancer patients with COVID-19 ranges from 0.9% to 3%, and they exhibit a severe clinical course with a mortality rate of 34.5%. Patients who recently received immunotherapy/immunosuppressive treatment are at higher risk. Therefore, measures such as reducing hospital visits for cancer patients, timely COVID-19 testing, and considering anti-cancer treatment should be taken to reduce the risk of infection and mortality.

JOURNAL OF CHEMOTHERAPY (2021)

Add to Collection

Article Health Care Sciences & Services

Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report

Lai Wei et al.

Summary: The case presented above described prolonged shedding of SARS-CoV-2 in a liver transplant patient with COVID-19. The patient, who had been receiving immunosuppressive treatment for over 11 years, showed a shedding duration of 52 days. This indicates a potential risk of prolonged shedding in immunosuppressed patients following COVID-19 infection.

ANNALS OF PALLIATIVE MEDICINE (2021)

Add to Collection

Article Immunology

Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium

Sapna A. Mehta et al.

Summary: Among kidney and liver transplant recipients with HIV, there was a 4% incidence rate of COVID-19 with high mortality. Most patients required hospitalization and aggressive treatment with high-dose steroids, tocilizumab, remdesivir, and convalescent plasma.

TRANSPLANTATION (2021)

Add to Collection

Article Respiratory System

Comparison of Clinical Features and Outcomes in Critically III Patients Hospitalized with COVID-19 versus Influenza

Natalie L. Cobb et al.

Summary: The study compared critically ill patients with COVID-19 and influenza, finding that patients with COVID-19 had a higher risk of mortality compared to patients with influenza. Although the clinical presentations were similar, patients with COVID-19 had differences in the need for mechanical ventilation, oxygenation improvement, and in-hospital mortality rates compared to patients with influenza.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Add to Collection

Review Immunology

COVID-19 and Solid Organ Transplantation: A Review Article

Yorg Azzi et al.

Summary: Solid organ transplantation has been significantly impacted by the coronavirus pandemic, with high mortality rates reported in recipients. The pandemic led to complexities in transplantation, including new questions regarding donor and recipient screening, and decisions on continuing transplantation based on clinical implications of COVID-19 infection. The clinical outcomes of COVID-19 in transplantation may vary depending on the type of transplanted organ and recipient comorbidities.

TRANSPLANTATION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

Isabel Schulien et al.

Summary: The study found that SARS-CoV-2 infection induces and forms functionally competent memory CD8(+) T cell responses, which can persist in some SARS-CoV-2 convalescent individuals. Even in the absence of virus-specific antibodies, these virus epitope-specific CD8(+) T cell responses are induced following infection.

NATURE MEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With Cancer

Shilpa Grover et al.

Summary: Gastrointestinal symptoms are common in hospitalized cancer patients with COVID-19, and can sometimes present without respiratory symptoms as the initial manifestation. Symptoms can be severe in a small percentage of patients.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection A Systematic Review and Meta-Analysis

Zi-yuan Dong et al.

Summary: The study found that the most common gastrointestinal symptoms in COVID-19 patients were diarrhea and anorexia, with the most significant abnormal liver function being elevated ALT. Additionally, 5% of patients developed digestive system disease and 3% had liver disease.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)

Add to Collection

Review Infectious Diseases

Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

Kathleen Chiotos et al.

Summary: Although COVID-19 is usually mild in children, some may develop severe or critical illness. Supportive care is typically enough for most cases, but for severe cases, remdesivir is suggested, with a duration of 5 days. It is not recommended to use hydroxychloroquine or other protease inhibitors for COVID-19 in children.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain

Ivan Guerra et al.

Summary: SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD) is not rare. Therapy for IBD is not related to COVID-19 severity, and COVID-19 does not appear to induce IBD flare-ups.

INFLAMMATORY BOWEL DISEASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Mayur Garg et al.

GUT (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Evidence for Gastrointestinal Infection of SARS-CoV-2

Fei Xiao et al.

GASTROENTEROLOGY (2020)

Add to Collection

Editorial Material Critical Care Medicine

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Haibo Zhang et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Add to Collection

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

Lei Pan et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Surgery

COVID-19 in solid organ transplant recipients: A single-center case series from Spain

Mario Fernandez-Ruiz et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Add to Collection

Article Oncology

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

L. Zhang et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Medicine, Research & Experimental

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

Daniel Batlle et al.

CLINICAL SCIENCE (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease

Jan Krzysztof Nowak et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Erica J. Brenner et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary

David T. Rubin et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study

Walker D. Redd et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

COVID-19 and immunomodulation in IBD

Markus F. Neurath

GUT (2020)

Add to Collection

Article Gastroenterology & Hepatology

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

Cristina Bezzio et al.

GUT (2020)

Add to Collection

Article Gastroenterology & Hepatology

Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

George Lau et al.

HEPATOLOGY INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD

Juan F. Burgueno et al.

INFLAMMATORY BOWEL DISEASES (2020)

Add to Collection

Editorial Material Medicine, Research & Experimental

SARS-CoV-2: a storm is raging

Savannah F. Pedersen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Shutoku Matsuyama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Gastroenterology & Hepatology

COVID-19: Abnormal liver function tests

Qingxian Cai et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Letter Gastroenterology & Hepatology

Management of patients with autoimmune liver disease during COVID-19 pandemic

Ana Lleo et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 productively infects human gut enterocytes

Mart M. Lamers et al.

SCIENCE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab

Michael T. Dolinger et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)

Add to Collection

Letter Dermatology

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor

F. Messina et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Marc Feldmann et al.

LANCET (2020)

Add to Collection

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Infection of bat and human intestinal organoids by SARS-CoV-2

Zhou Jie et al.

NATURE MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Covid-19 and Kidney Transplantation

Enver Akalin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Covid-19 in Critically Ill Patients in the Seattle Region - Case Series

Pavan K. Bhatraju et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19

Harmony R. Reynolds et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Microbiology

Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2

Saif Ur Rehman et al.

PATHOGENS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Liver transplant immunosuppression during the covid-19 pandemic

Xavier Forns et al.

GASTROENTEROLOGIA Y HEPATOLOGIA (2020)

Add to Collection

Article Gastroenterology & Hepatology

COVID-19 in an international European liver transplant recipient cohort

Chiara Becchetti et al.

GUT (2020)

Add to Collection

Article Medicine, General & Internal

Vascular occlusion by neutrophil extracellular traps in COVID-19

Moritz Leppkes et al.

EBIOMEDICINE (2020)

Add to Collection

Letter Gastroenterology & Hepatology

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China

Ping An et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Kenneth E. Remy et al.

JCI INSIGHT (2020)

Add to Collection

Article Virology

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19

Kishan P. Patel et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce

F. Magro et al.

JOURNAL OF CROHNS & COLITIS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Benjamin J. Meckiff et al.

CELL (2020)

Add to Collection

Article Immunology

Single-cell landscape of immunological responses in patients with COVID-19

Ji-Yuan Zhang et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

COVID-19 and liver transplantation

Tommaso Di Maira et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Immunology

Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center

Stephanie G. Yi et al.

TRANSPLANTATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

David Simon et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

Sara De Biasi et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Add to Collection

Article Immunology

Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Yanchun Peng et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Editorial Material Immunology

T cells in COVID-19-united in diversity

Leo Swadling et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Editorial Material Medicine, General & Internal

A living WHO guideline on drugs for covid-19

Francois Lamontagne et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Review Pharmacology & Pharmacy

Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis

Wenwen Cheng et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Article Immunology

MAIT cell activation and dynamics associated with COVID-19 disease severity

Tiphaine Parrot et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19

Hisayuki Shuto et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Gwilym J. Webb et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Infectious Diseases

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

Bernadette Schurink et al.

LANCET MICROBE (2020)

Add to Collection

Article Medicine, General & Internal

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

Mariangela Allocca et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports

Felipe Alconchel et al.

WORLD JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Immunology

Cross-reactive memory T cells and herd immunity to SARS-CoV-2

Marc Lipsitch et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?

Abdullah Abdullah et al.

VISCERAL MEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients

Alessio Gerussi et al.

HEPATOLOGY COMMUNICATIONS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances

Sebastian Zundler et al.

GUT (2019)

Add to Collection

Review Immunology

Targeting immune cell circuits and trafficking in inflammatory bowel disease

Markus F. Neurath

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

B. E. Sands et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Gastroenterology & Hepatology

Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo

Anika Fischer et al.

GUT (2016)

Add to Collection

Article Pharmacology & Pharmacy

Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus

Kai-Wen Cheng et al.

ANTIVIRAL RESEARCH (2015)

Add to Collection

Article Virology

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir

Javier Carbajo-Lozoya et al.

VIRUS RESEARCH (2014)

Add to Collection

Article Medicine, General & Internal

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Medicine, General & Internal

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

William J. Sandborn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Gastroenterology & Hepatology

Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease

Garret Cullen et al.

GUT (2012)

Add to Collection

Article Gastroenterology & Hepatology

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study

Gionata Fiorino et al.

INFLAMMATORY BOWEL DISEASES (2012)

Add to Collection

Article Multidisciplinary Sciences

ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation

Tatsuo Hashimoto et al.

NATURE (2012)

Add to Collection

Article Medicine, General & Internal

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

William J. Sandborn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Add to Collection

Article Cell Biology

Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice

John J. Byrnes et al.

INFLAMMATION RESEARCH (2009)

Add to Collection

Article Gastroenterology & Hepatology

A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

William J. Sandborn et al.

GASTROENTEROLOGY (2008)

Add to Collection

Article Immunology

Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection

AC Allison et al.

TRANSPLANTATION (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.